Did Thomas Tuberville sell Idexx Laboratories stock?
Republican · U.S. Senate · Alabama
Latest filing Feb 14, 2024
Yes. Thomas Tuberville disclosed 2 sales of Idexx Laboratories (IDXX) stock between Oct 5, 2022 and Jan 22, 2024, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.
Did Thomas Tuberville sell Idexx Laboratories stock?
Yes. Thomas Tuberville disclosed 2 sales of Idexx Laboratories (IDXX) stock between Oct 5, 2022 and Jan 22, 2024, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.
How big were Thomas Tuberville's Idexx Laboratories trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.
Did Thomas Tuberville make these Idexx Laboratories trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Thomas Tuberville still own Idexx Laboratories stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Thomas Tuberville report these trades?
The latest filing is dated Feb 14, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Loading